The University of Arizona
Map Home
Loading...
Adjust height of sidebar
KMap

Grant

A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase II Study to Assess the Efficacy and Safety of Daily OM-85 Treatment Versus Placebo Given on Top of Standard of Care in Children Aged

Sponsored by OM Pharma SA (Switzerland)

Active
$814.9K Funding
9 People
External

Related Topics

People